Status:
NOT_YET_RECRUITING
Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo.
Lead Sponsor:
Institute of Tropical Medicine, Belgium
Collaborating Sponsors:
ANRS | Maladies infectieuses émergentes
Institut Pasteur
Conditions:
Plague
Bubonic; Plague, Skin
Eligibility:
All Genders
5+ years
Brief Summary
This study is being done to learn more about the disease in Ituri and to evaluate a new rapid test that may help doctors find the disease more quickly. This research includes characterisation of clini...
Detailed Description
Plague is a life-threatening infection caused by the bacterium Yersinia pestis, which is highly endemic in the Ituri Province of the Democratic Republic of Congo (DRC) and associated with recurrent ri...
Eligibility Criteria
Inclusion
- All participants (aged ≥5 year old) within Rethy, Logo and Aru health zones, presenting with possible symptoms of bubonic and/or pneumonic plague according to WHO definition
- Willing to provide voluntary consent (or voluntary assent and parental consent in case of minors.
Exclusion
- Participants not eligible, able, or willing to undergo study procedures
- Children \<5 years of age
- Participants on antibiotic treatment ≥48h prior to recruitment
Key Trial Info
Start Date :
January 2 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 2 2029
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07174648
Start Date
January 2 2026
End Date
January 2 2029
Last Update
September 19 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.